On the identifiability of pharmacokinetic parameters in dynamic contrast-enhanced imaging.
about
Incorporating a vascular term into a reference region model for the analysis of DCE-MRI data: a simulation studyTumor metabolism and perfusion in head and neck squamous cell carcinoma: pretreatment multimodality imaging with 1H magnetic resonance spectroscopy, dynamic contrast-enhanced MRI, and [18F]FDG-PET.Development and evaluation of TWIST Dixon for dynamic contrast-enhanced (DCE) MRI with improved acquisition efficiency and fat suppression.Suitability of pharmacokinetic models for dynamic contrast-enhanced MRI of abdominal aortic aneurysm vessel wall: a comparisonUsing dynamic contrast-enhanced magnetic resonance imaging data to constrain a positron emission tomography kinetic model: theory and simulationsPharmacokinetic mapping for lesion classification in dynamic breast MRI.Optimal acquisition and modeling parameters for accurate assessment of low Ktrans blood-brain barrier permeability using dynamic contrast-enhanced MRITreatment response assessment of breast masses on dynamic contrast-enhanced magnetic resonance scans using fuzzy c-means clustering and level set segmentationA novel approach to tracer-kinetic modeling for (macromolecular) dynamic contrast-enhanced MRI.Sensitivity of quantitative metrics derived from DCE MRI and a pharmacokinetic model to image quality and acquisition parameters.A novel framework for evaluating the image accuracy of dynamic MRI and the application on accelerated breast DCE MRI.Subchondral fluid dynamics in a model of osteoarthritis: use of dynamic contrast-enhanced magnetic resonance imaging.Optimized pharmacokinetic modeling for the detection of perfusion differences in skeletal muscle with DCE-MRI: effect of contrast agent size.An improved coverage and spatial resolution--using dual injection dynamic contrast-enhanced (ICE-DICE) MRI: a novel dynamic contrast-enhanced technique for cerebral tumors.An efficient calculation method for pharmacokinetic parameters in brain permeability study using dynamic contrast-enhanced MRI.Sampling requirements in DCE-MRI based analysis of high grade gliomas: simulations and clinical results.Precision analysis of kinetic modelling estimates in dynamic contrast enhanced MRI.
P2860
Q31153802-350A19B5-DFDC-4C65-9FFC-093F21CCBAEEQ33793870-D66BE151-2CD4-4C45-9BB7-EE4B7742CE51Q34250813-4BF15C66-5F76-4784-AAE8-F0F96FF46A06Q35009084-896BBB30-B2D2-4263-9C5C-A15EAE1DD769Q35039987-C411AB76-EB53-45EC-9615-EAF367F39A6DQ36311542-72B84253-F046-4113-9B51-2BB42923A372Q36501363-3375AA53-41E2-402A-B6CD-F7D64CAD726DQ37412241-9783ECC3-24AB-45D1-96F8-9C9890528083Q41110202-F1B40E49-73FB-47E4-9A47-CC1DF3ECFA89Q41973243-B1BCD889-B0CA-416F-B9C5-D28D7F347738Q42689810-02E99B75-E55D-4CBC-8823-51699F64E1B9Q42733520-1BCA7C85-19E0-4A53-95C2-ED9A7D330D29Q43464254-8FE1DEC2-F4DD-47EB-8F70-D30C2BE38071Q47389075-0DF91813-1449-4F8B-91E8-35B0E37D9A65Q48256960-ED79C251-68EE-4ECB-A085-BDEF850FFD98Q48327067-B7CEC33D-9991-4AAE-911D-07F8B02C4CC2Q49076621-1F18FADE-C713-458B-89B2-8E1344A14C92
P2860
On the identifiability of pharmacokinetic parameters in dynamic contrast-enhanced imaging.
description
2007 nî lūn-bûn
@nan
2007年の論文
@ja
2007年学术文章
@wuu
2007年学术文章
@zh
2007年学术文章
@zh-cn
2007年学术文章
@zh-hans
2007年学术文章
@zh-my
2007年学术文章
@zh-sg
2007年學術文章
@yue
2007年學術文章
@zh-hant
name
On the identifiability of phar ...... mic contrast-enhanced imaging.
@en
On the identifiability of phar ...... mic contrast-enhanced imaging.
@nl
type
label
On the identifiability of phar ...... mic contrast-enhanced imaging.
@en
On the identifiability of phar ...... mic contrast-enhanced imaging.
@nl
prefLabel
On the identifiability of phar ...... mic contrast-enhanced imaging.
@en
On the identifiability of phar ...... mic contrast-enhanced imaging.
@nl
P50
P356
P1476
On the identifiability of pharmacokinetic parameters in dynamic contrast-enhanced imaging
@en
P2093
Paul P J van den Bosch
P2860
P304
P356
10.1002/MRM.21336
P577
2007-08-01T00:00:00Z